Fiber, protein, berberine and curcumin get a look, though experts quoted say none come close to the effect of prescription GLP-1 drugs.
Recap by typeshit. Full story at health.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A short Philstar Life item on PIONEER 8, a trial of oral semaglutide. The material gives only the title, so tap through for the details.
A post hoc MRI look at 55 people, shown at EASD 2026, found average liver fat dropped from 8.8% to 3.1% by week 72. No placebo comparison was reported.
The appeal board went against its preliminary opinion. JUVE Patent says generic semaglutide could reach Europe as early as 2031 instead of 2037.
Loading…